Status:
UNKNOWN
Immunity and Infections in the Psychiatric Population
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
COVID
Psychiatric Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of this multicenter cohort study is to determine the degree of COVID19 infection immunization of a population of psychiatric patients. The secondary objective of this cohort follow...
Detailed Description
All patients accepting to participate will be included in participating psychiatry services and will have a COVID Serological Test for Inclusion with confirmation at J15 including immune-genetics data...
Eligibility Criteria
Inclusion
- Adult patient
- Hospitalized in one of the participating psychiatric wards during the inclusion period
- Signed informed consent
Exclusion
- Inability to obtain the consent of the patient or legal representative, if applicable
- Patient under safeguard of justice
Key Trial Info
Start Date :
January 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04381845
Start Date
January 10 2021
End Date
December 10 2023
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hôpitaux de Paris
Paris, Île-de-France Region, France